vimizim.com
#4,994,711
Global Rankeez rank — last updated 01 Sep 2026
Better than 95.1% of the 102,887,824 domains we track
Best rank recorded
#4,994,711
2026-09
Worst rank recorded
#28,103,088
2026-06
Tracked since
2026-06
4 monthly snapshots
Source breakdown
Rankeez combines several independent public rankings. Here's how vimizim.com scores in each:
| Source | Rank |
|---|---|
| DomCop / OpenPageRank | #2,913,407 |
| CommonCrawl (hyperlink graph) | #8,128,355 |
See how these sources are combined and cross-validated →
Ranking history
vimizim.com's rank across 4 monthly snapshots. ▲ improved by 23,108,377 since 2026-06
| Month | Rank |
|---|---|
| 2026-06 | #28,103,088 |
| 2026-07 | #21,798,923 |
| 2026-08 | #21,791,605 |
| 2026-09 | #4,994,711 |
JSON API
{
"vimizim.com": 4994711,
"history": {
"2026-06": 28103088,
"2026-07": 21798923,
"2026-08": 21791605,
"2026-09": 4994711
}
}
GET https://rankeez.com/api/vimizim.com.json · see API docs →
More about vimizim.com
vimizim.com — page content & similar sites →
VIMIZIM® (elosulfase alfa) is the first and only enzyme replacement therapy approved for people with Morquio A. View important safety information, including risk of anaphylaxis.
vimizim.com — full site profile →
WHOIS, tech stack and extended traffic history for vimizim.com.